Solventum (NYSE: SOLV) announced today it has completed the acquisition of Acera Surgical (Acera), a privately held bioscience company focused on developing and commercializing fully engineered ...

Solventum SOLV announced the acquisition of Acera Surgical, which specializes in advanced synthetic treatment options for ...

The S&P healthcare index (XLV) saw moderate gains in 2025, reaching a YTD increase of 12.2% by mid-December, though it fell short of its May highs. The sector is the sixth-highest performing sector ...

With a market cap of $11.5 billion, Solventum Corporation (SOLV) is a U.S.-based healthcare company that was spun off from 3M on April 1, 2024. Headquartered in Maplewood, Minnesota, Solventum focuses ...

Full year organic sales growth guidance was raised to a range of 2% to 3%, a 50 basis point increase above prior guidance. Excluding planned SKU exits, annual growth outlook is 2.5% to 3.5%. Earnings ...

Solventum, 3M’s health care spinoff based in Maplewood, is exploring a sale of its purification and filtration business, the Wall Street Journal reported Thursday citing unnamed sources. Solventum’s ...

On Thursday, Solventum (NYSE:SOLV) hosted its 2025 Investor Day, during which it outlined its strategic priorities, its business segments, and its long-range plan (LRP) to drive growth and value ...

Saint Paul, Minnesota-based Solventum Corporation (SOLV) develops, manufactures, and commercializes a broad portfolio of solutions that leverages material & data science, clinical research, and ...

Solventum has delivered stronger performance than the Nasdaq Composite over the past year, reinforcing analysts’ moderate ...

Solventum (NYSE:SOLV) announced today that it completed its previously announced acquisition of Acera Surgical.